Works by Burg, Sjoerd


Results: 129
    1

    Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines.

    Published in:
    ChemBioChem, 2021, v. 22, n. 7, p. 1215, doi. 10.1002/cbic.202000687
    By:
    • Ende, Thomas C.;
    • Heuts, Jeroen M. M.;
    • Gential, Geoffroy P. P.;
    • Visser, Marten;
    • Graaff, Michel J.;
    • Ho, Nataschja I.;
    • Jiskoot, Wim;
    • Valentijn, A. Rob P. M.;
    • Meeuwenoord, Nico J.;
    • Overkleeft, Herman S.;
    • Codée, Jeroen D. C.;
    • Burg, Sjoerd H.;
    • Verdegaal, Els M. E.;
    • Marel, Gijsbert A.;
    • Ossendorp, Ferry;
    • Filippov, Dmitri V.
    Publication type:
    Article
    2
    3

    Harmonization of Immune Biomarker Assays for Clinical Studies.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 108, p. 1, doi. 10.1126/scitranslmed.3002785
    By:
    • van der Burg, Sjoerd H.;
    • Kalos, Michael;
    • Gouttefangeas, Cécile;
    • Janetzki, Sylvia;
    • Ottensmeier, Christian;
    • Welters, Marij J. P.;
    • Romero, Pedro;
    • Britten, Cedrik M.;
    • Hoos, Axel
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Therapeutic cancer vaccines.

    Published in:
    Journal of Clinical Investigation, 2015, v. 125, n. 9, p. 3401, doi. 10.1172/JCI80009
    By:
    • Melief, Cornelis J. M.;
    • van Hall, Thorbald;
    • Arens, Ramon;
    • Ossendorp, Ferry;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    12
    13
    14

    Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.

    Published in:
    European Journal of Immunology, 2013, v. 43, n. 10, p. 2554, doi. 10.1002/eji.201343324
    By:
    • Rosalia, Rodney A.;
    • Quakkelaar, Esther D.;
    • Redeker, Anke;
    • Khan, Selina;
    • Camps, Marcel;
    • Drijfhout, Jan W.;
    • Silva, Ana Luisa;
    • Jiskoot, Wim;
    • Hall, Thorbald;
    • Veelen, Peter A.;
    • Janssen, George;
    • Franken, Kees;
    • Cruz, Luis J.;
    • Tromp, Angelino;
    • Oostendorp, Jaap;
    • Burg, Sjoerd H.;
    • Ossendorp, Ferry;
    • Melief, Cornelis J. M.
    Publication type:
    Article
    15
    16
    17

    Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.

    Published in:
    International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8707, doi. 10.3390/ijms23158707
    By:
    • van Elsas, Marit J.;
    • van der Schoot, Johan M. S.;
    • Bartels, Alexander;
    • Steuten, Kas;
    • van Dalen, Duco;
    • Wijfjes, Zacharias;
    • Figdor, Carl G.;
    • van Hall, Thorbald;
    • van der Burg, Sjoerd H.;
    • Verdoes, Martijn;
    • Scheeren, Ferenc A.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.

    Published in:
    Science Translational Medicine, 2016, v. 8, n. 334, p. 1, doi. 10.1126/scitranslmed.aad8307
    By:
    • Welters, Marij J.;
    • van der Sluis, Tetje C.;
    • van Meir, Hélène;
    • Loof, Nikki M.;
    • van Ham, Vanessa J.;
    • van Duikeren, Suzanne;
    • Santegoets, Saskia J.;
    • Arens, Ramon;
    • de Kam, Marieke L.;
    • Cohen, Adam F.;
    • van Poelgeest, Mariette I.;
    • Kenter, Gemma G.;
    • Kroep, Judith R.;
    • Burggraaf, Jacobus;
    • Melief, Cornelis J.;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    25

    Anti-CTLA-4 therapy broadens the melanoma-reactive CD8<sup>+</sup> T cell response.

    Published in:
    Science Translational Medicine, 2014, v. 6, n. 254, p. 1, doi. 10.1126/scitranslmed.3008918
    By:
    • Kvistborg, Pia;
    • Philips, Daisy;
    • Kelderman, Sander;
    • Hageman, Lois;
    • Ottensmeier, Christian;
    • Joseph-Pietras, Deborah;
    • Welters, Marij J. P.;
    • van der Burg, Sjoerd;
    • Kapiteijn, Ellen;
    • Michielin, Olivier;
    • Romano, Emanuela;
    • Linnemann, Carsten;
    • Speiser, Daniel;
    • Blank, Christian;
    • Haanen, John B.;
    • Schumacher, Ton N.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy.

    Published in:
    International Journal of Cancer, 2007, v. 121, n. 3, p. 606, doi. 10.1002/ijc.22710
    By:
    • Lambeck, Annechien;
    • Leffers, Ninke;
    • Hoogeboom, Baukje-Nynke;
    • Sluiter, Wim;
    • Hamming, Ineke;
    • Klip, Harry;
    • ten Hoor, Klaske;
    • Esajas, Martha;
    • van Oven, Magda;
    • Drijfhout, Jan-Wouter;
    • Platteel, Inge;
    • Offringa, Rienk;
    • Hollema, Harry;
    • Melief, Kees;
    • van der Burg, Sjoerd;
    • van der Zee, Ate;
    • Daemen, Toos;
    • Nijman, Hans
    Publication type:
    Article
    32
    33

    Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.

    Published in:
    International Journal of Cancer, 2006, v. 118, n. 3, p. 675, doi. 10.1002/ijc.21394
    By:
    • van Poelgeest, Mariëtte I.E.;
    • Nijhuis, Esther R.;
    • Kwappenberg, Kitty M.C.;
    • Hamming, Ineke E.;
    • Wouter Drijfhout, Jan;
    • Fleuren, Gert Jan;
    • van der Zee, Ate G.J.;
    • Melief, Cornelis J.M.;
    • Kenter, Gemma G.;
    • Nijman, Hans W.;
    • Offringa, Rienk;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    34
    35
    36

    Natural T-helper immunity against human papillomavirus type 16 (hpv16) e7-derived peptide epitopes in patients with hpv16-positive cervical lesions: Identification of 3 human leukocyte antigen class ii-restricted epitopes.

    Published in:
    International Journal of Cancer, 2001, v. 91, n. 5, p. 612, doi. 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1119&gt;3.0.CO;2-C
    By:
    • van der Burg, Sjoerd H.;
    • Ressing, Maaike E.;
    • Kwappenberg, Kitty M.C.;
    • de Jong, Annemieke;
    • Straathof, Karin;
    • de Jong, Joan;
    • Geluk, Annemieke;
    • van Meijgaarden, Krista E.;
    • Franken, Kees L.M.C.;
    • Ottenhoff, Tom H.M.;
    • Fleuren, Gert Jan;
    • Kenter, Gemma;
    • Melief, Cornelis J.M.;
    • Offringa, Rienk
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy.

    Published in:
    Immunity & Ageing, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12979-024-00463-y
    By:
    • Tran Van Hoi, Estelle;
    • Santegoets, Saskia J.;
    • Mooijaart, Simon P.;
    • Van Heemst, Diana;
    • Özkan, Asli;
    • Verdegaal, Elizabeth M. E.;
    • Slingerland, Marije;
    • Kapiteijn, Ellen;
    • van der Burg, Sjoerd H.;
    • Portielje, Johanneke E. A.;
    • Welters, Marij J. P.;
    • de Glas, Nienke A.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.

    Published in:
    Cancer Immunology, Immunotherapy, 2017, v. 66, n. 9, p. 1163, doi. 10.1007/s00262-017-2006-y
    By:
    • Samuels, Sanne;
    • Marijne Heeren, A.;
    • Zijlmans, Henry;
    • Welters, Marij;
    • Berg, Joost;
    • Philips, Daisy;
    • Kvistborg, Pia;
    • Ehsan, Ilina;
    • Scholl, Suzy;
    • Nuijen, Bastiaan;
    • Schumacher, Ton;
    • Beurden, Marc;
    • Jordanova, Ekaterina;
    • Haanen, John;
    • Burg, Sjoerd;
    • Kenter, Gemma
    Publication type:
    Article
    50